0001127602-20-031192.txt : 20201211
0001127602-20-031192.hdr.sgml : 20201211
20201211165913
ACCESSION NUMBER: 0001127602-20-031192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simon, Christopher
CENTRAL INDEX KEY: 0001674993
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 201384128
BUSINESS ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 781-356-7100
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0403
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-12-10
0000313143
HAEMONETICS CORP
HAE
0001674993
Simon, Christopher
125 SUMMER STREET
BOSTON
MA
02110
1
1
President & CEO
Common Stock
2020-12-10
5
G
0
E
194369
0
D
170941
D
Non-qualified Stock Option (Right to Buy)
28.615
2017-06-29
2023-06-29
Common Stock
196746
196746
D
Non-qualified Stock Option (Right to Buy)
41.64
2018-06-06
2024-06-06
Common Stock
104516
104516
D
Non-qualified Stock Option (Right to Buy)
93.52
2019-06-11
2025-06-11
Common Stock
40443
40443
D
Non-qualified Stock Option (Right to Buy)
98.025
2020-05-14
2026-05-14
Common Stock
48971
48971
D
Non-qualified Stock Option (Right to Buy)
103.37
2021-05-18
2027-05-18
Common Stock
49105
49105
D
These securities were transferred by the reporting person as a gift without any consideration to the Simon Family 2020 Irrevocable Trust for the benefit of the reporting person's children, which trust has an independent trustee.
This number includes unvested restricted stock units previously reported.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
2020-12-11